Search Results - "Montero Alvarez, J.L."

Prevalence and Predictors of Metabolic Syndrome After Liver Transplantation by Vida Perez, L, Montero Alvarez, J.L, Poyato Gonzalez, A, Briceño Delgado, J, Costan Rodero, G, Fraga Rivas, E, Barrera Baena, P, De la Mata Garcia, M

“…Abstract Background The development of metabolic syndrome (MS) after liver transplantation (LT) is a major source of mortality derived from cardiovascular…”
Get full text

Combined Liver-Kidney Transplantation: Survey of a Single Center in Spain by Haad, C. Rodelo, Rodriguez-Benot, A, Martinez-Vaquera, S, Navarro-Cabello, M.D, Aguera-Morales, M.L, Ruiz de Mier, M.V. Pendon, Montero-Alvarez, J.L, Mata-Garcia, M. de la, Briceño-Delgado, J, Aljama-Garcia, P

“…Abstract Background Renal dysfunction is a common complication of advanced liver failure and liver transplantation. Since the introduction of the MELD criteria…”
Get full text

560 DROP-OUT ON THE LIVER TRANSPLANTATION WAITING LIST IN A MELD-BASED ALLOCATION MODEL. MULTICENTRIC STUDY OF CAUSES AND RISK FACTORS by Pleguezuelo, M, Benitez, J.M, Poyato, A, Montero Alvarez, J.L, Lopez-Cillero, P, Gomez-Bravo, J.M, Pascasio, J.M, Santoyo, J, Rodrigo, J.M, Ferron, J.A, Nogueras, F, Diaz-Aunion, C, De la Mata, M

Get full text

178 IMMUNOSUPPRESSION AND HEPATOCELLULAR CARCINOMA RECURRENCE AFTER LIVER TRANSPLANTATION by Rodríguez-Perálvarez, M, Pieri, G, Naveas, M.C, Tsochatzis, E, García-Caparrós, C, O'Beirne, J, Poyato-González, A, Ferrín-Sa'nchez, G, Patch, D, Montero-Álvarez, J.L, Thorburn, D, Briceño, J, De la Mata, M, Burroughs, A.K

Get full text

Biliary Complications After Liver Transplantation Using Side-to-Side Choledochocholedochostomy Reconstruction With or Without T-Tube by Benítez Cantero, J.M, Costán Rodero, G, Montero Álvarez, J.L, Ayllón Terán, M.D, Naveas Polo, C, Fraga Rivas, E, Barrera Baena, P, Poyato González, A, López Cillero, P, Luque Molina, A, De la Mata Garcia, M

“…Abstract Background Biliary complications are a frequent cause of morbidity, graft loss, and death after orthotopic liver transplantation (OLT). The…”
Get full text

CA209-9DX: phase III, randomized, double-blind study of adjuvant nivolumab vs placebo for patients with hepatocellular carcinoma (HCC) at high risk of recurrence after curative resection or ablation by Jimenez Exposito, M.J., Akce, M., Montero Alvarez, J.L., Assenat, E., Balart, L.A., Baron, A.D., Decaens, T., Heurgue-Berlot, A., Martin, A.O., Paik, S.W., Poulart, V., Sehbai, A.S., Takemura, N., Yoon, J.-H.

Get full text

177 EVALUATION OF PHYSICIAN AGREEMENT FOR DEFINING “CLINICAL SUSPICION OF REJECTION” IN LIVER TRANSPLANTATION by Rodríguez-Perálvarez, M, Germani, G, Hogan, B, Poyato- González, A, O'Beirne, J, Senzolo, M, Montero-Álvarez, J.L, Patch, D, Dhillon, A.P, Burra, P, De la Mata, M, Burroughs, A.K

Get full text